BIOMAT Database Logo BIOMAT Database Logo

Comparison of saliva and serum for human immunodeficiency virus type 1 antibody testing in Uganda using a rapid recombinant assay. 1996

R M Grant, and E M Piwowar, and E Katongole-Mbidde, and W Muzawalu, and S Rugera, and J Abima, and S L Stramer, and P Kataaha, and B Jackson
University of California, San Francisco, USA. rgrant@hsa.uscf.edu

The accuracy and acceptability of saliva human immunodeficiency virus type 1 (HIV-1) antibody testing were compared with serum testing in a study of paired specimens from HIV-1-seropositive and HIV-1-seronegative Ugandan adults attending a clinic for sexually transmitted diseases. Saliva collection was performed with the Omni-sal device (Saliva Diagnostic Systems, Vancouver, Wash.), and antibody testing was performed by a rapid filter paper assay (Test-Pack; Abbott Laboratories, Abbott Park, Ill.). Relative to serum testing, the sensitivity of saliva testing was 95% (195 of 205) and the specificity was 99% (295 of 297). The sensitivity of saliva testing was higher for patients with elevated levels of beta-2 microglobulin in sera and greater numbers of HIV-1-related symptoms. Pre- and poststudy interviews indicated that saliva testing did not foster inordinate fears of saliva exposure. The development of saliva tests that are inexpensive and do not require electricity is needed.

UI MeSH Term Description Entries
D008297 Male Males
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001613 beta 2-Microglobulin An 11-kDa protein associated with the outer membrane of many cells including LYMPHOCYTES. It is the small subunit of MHC CLASS I MOLECULES. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, CEREBROSPINAL FLUID, and urine of healthy individuals, and to a much greater degree in the urine and plasma of patients with tubular PROTEINURIA, renal failure, or kidney transplants. Thymotaxin,beta 2 Microglobulin
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D014454 Uganda A republic in eastern Africa, south of SUDAN and west of KENYA. Its capital is Kampala. Republic of Uganda

Related Publications

R M Grant, and E M Piwowar, and E Katongole-Mbidde, and W Muzawalu, and S Rugera, and J Abima, and S L Stramer, and P Kataaha, and B Jackson
[Recombinant virus assay: a rapid assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates].
October 2002, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
R M Grant, and E M Piwowar, and E Katongole-Mbidde, and W Muzawalu, and S Rugera, and J Abima, and S L Stramer, and P Kataaha, and B Jackson
Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant-antigen immunoblot assay.
February 1991, Transfusion,
R M Grant, and E M Piwowar, and E Katongole-Mbidde, and W Muzawalu, and S Rugera, and J Abima, and S L Stramer, and P Kataaha, and B Jackson
Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates.
January 1994, Antimicrobial agents and chemotherapy,
R M Grant, and E M Piwowar, and E Katongole-Mbidde, and W Muzawalu, and S Rugera, and J Abima, and S L Stramer, and P Kataaha, and B Jackson
Comparison of testing saliva and serum for detection of antibody to human immunodeficiency virus in Jamaica, West Indies.
December 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
R M Grant, and E M Piwowar, and E Katongole-Mbidde, and W Muzawalu, and S Rugera, and J Abima, and S L Stramer, and P Kataaha, and B Jackson
Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay.
September 1996, AIDS research and human retroviruses,
R M Grant, and E M Piwowar, and E Katongole-Mbidde, and W Muzawalu, and S Rugera, and J Abima, and S L Stramer, and P Kataaha, and B Jackson
Rapid phenotypic assay for human immunodeficiency virus type 1 protease using in vitro translation.
October 2002, Journal of virological methods,
R M Grant, and E M Piwowar, and E Katongole-Mbidde, and W Muzawalu, and S Rugera, and J Abima, and S L Stramer, and P Kataaha, and B Jackson
Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays.
October 2005, Journal of clinical microbiology,
R M Grant, and E M Piwowar, and E Katongole-Mbidde, and W Muzawalu, and S Rugera, and J Abima, and S L Stramer, and P Kataaha, and B Jackson
Correlation between saliva and serum for human immunodeficiency virus 1 and 2 antibodies using a rapid test system.
July 1995, Annals of the Academy of Medicine, Singapore,
R M Grant, and E M Piwowar, and E Katongole-Mbidde, and W Muzawalu, and S Rugera, and J Abima, and S L Stramer, and P Kataaha, and B Jackson
Performance characteristics of a rapid western blot assay system for antibody to human immunodeficiency virus type 1.
August 1991, Journal of virological methods,
R M Grant, and E M Piwowar, and E Katongole-Mbidde, and W Muzawalu, and S Rugera, and J Abima, and S L Stramer, and P Kataaha, and B Jackson
Comparison of saliva and blood for human immunodeficiency virus prevalence testing.
April 1991, The Journal of infectious diseases,
Copied contents to your clipboard!